NLCAX
Price
$53.67
Change
-$0.19 (-0.35%)
Updated
Aug 15 closing price
Net Assets
838.54M
RGACX
Price
$82.10
Change
-$0.06 (-0.07%)
Updated
Aug 15 closing price
Net Assets
329.22B
Interact to see
Advertisement

NLCAX vs RGACX

Header iconNLCAX vs RGACX Comparison
Open Charts NLCAX vs RGACXBanner chart's image
Voya Large-Cap Growth A
Price$53.67
Change-$0.19 (-0.35%)
VolumeN/A
Net Assets838.54M
American Funds Growth Fund of Amer R3
Price$82.10
Change-$0.06 (-0.07%)
VolumeN/A
Net Assets329.22B
NLCAX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NLCAX vs. RGACX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NLCAX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 329B vs. NLCAX (839M). RGACX pays higher dividends than NLCAX: RGACX (0.07) vs NLCAX (0.00). NLCAX was incepted earlier than RGACX: NLCAX (28 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than NLCAX (0.84). NLCAX is a more actively managed with annual turnover of: 51.00 vs. RGACX (25.00). RGACX has a lower initial minimum investment than NLCAX: RGACX (250) vs NLCAX (1000). NLCAX annual gain was more profitable for investors over the last year : 16.07 vs. RGACX (14.08). RGACX return over 5 years is better than : 41.95 vs. NLCAX (7.77).
NLCAXRGACXNLCAX / RGACX
Total Expense Ratio0.840.9489%
Annual Report Gross Expense Ratio0.840.9489%
Fund Existence28 years23 years-
Gain YTD9.24114.04466%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets839M329B0%
Annual Yield % from dividends0.000.07-
Returns for 1 year16.0714.08114%
Returns for 3 years30.5541.1974%
Returns for 5 years7.7741.9519%
Returns for 10 years60.5983.6872%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STLA9.790.05
+0.51%
Stellantis NV
MLTX54.39-0.49
-0.89%
MoonLake Immunotherapeutics
MATW23.77-0.48
-1.98%
Matthews International Corp
TKLF3.53-0.26
-6.81%
Tokyo Lifestyle Co Ltd
BW1.56-0.12
-7.14%
Babcock & Wilcox Enterprises